boehringer glp 1 dual-acting obesity shot hits mark in Phase 3 trial Boehringer Ingelheim presents liver-focused obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10


























